21 C.F.R. Subpart E—Manufacturer Reporting Requirements
Title 21 - Food and Drugs
(a) If you are a manufacturer, you must report to us no later than 30 calendar days after the day that you receive or otherwise become aware of information, from any source, that reasonably suggests that a device that you market: (1) May have caused or contributed to a death or serious injury; or (2) Has malfunctioned and this device or a similar device that you market would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur. (b) What information does FDA consider “reasonably known” to me? (1) You must submit all information required in this subpart E that is reasonably known to you. We consider the following information to be reasonably known to you: (i) Any information that you can obtain by contacting a user facility, importer, or other initial reporter; (ii) Any information in your possession; or (iii) Any information that you can obtain by analysis, testing, or other evaluation of the device. (2) You are responsible for obtaining and submitting to us information that is incomplete or missing from reports submitted by user facilities, importers, and other initial reporters. (3) You are also responsible for conducting an investigation of each event and evaluating the cause of the event. If you cannot submit complete information on a report, you must provide a statement explaining why this information was incomplete and the steps you took to obtain the information. If you later obtain any required information that was not available at the time you filed your initial report, you must submit this information in a supplemental report under §803.56. You must include the following information in your reports, if known or reasonably known to you, as described in §803.50(b). These types of information correspond generally to the format of FDA Form 3500A: (a) Patient information (Form 3500A, Block A). You must submit the following: (1) Patient name or other identifier; (2) Patient age at the time of event, or date of birth; (3) Patient gender; and (4) Patient weight. (b) Adverse event or product problem (Form 3500A, Block B). You must submit the following: (1) Identification of adverse event or product problem; (2) Outcomes attributed to the adverse event (e.g., death or serious injury). An outcome is considered a serious injury if it is: (i) Life-threatening injury or illness; (ii) Disability resulting in permanent impairment of a body function or permanent damage to a body structure; or (iii) Injury or illness that requires intervention to prevent permanent impairment of a body structure or function; (3) Date of event; (4) Date of report by the initial reporter; (5) Description of the event or problem, including a discussion of how the device was involved, nature of the problem, patient followup or required treatment, and any environmental conditions that may have influenced the event; (6) Description of relevant tests, including dates and laboratory data; and (7) Other relevant patient history including preexisting medical conditions. (c) Device information (Form 3500A, Block D). You must submit the following: (1) Brand name; (2) Type of device; (3) Your name and address; (4) Operator of the device (health professional, patient, lay user, other); (5) Expiration date; (6) Model number, catalog number, serial number, lot number, or other identifying number; (7) Date of device implantation (month, day, year); (8) Date of device explantation (month, day, year); (9) Whether the device was available for evaluation, and whether the device was returned to you, and if so, the date it was returned to you; and (10) Concomitant medical products and therapy dates. (Do not report products that were used to treat the event.) (d) Initial reporter information (Form 3500A, Block E). You must submit the following: (1) Name, address, and phone number of the reporter who initially provided information to you, or to the user facility or importer; (2) Whether the initial reporter is a health professional; (3) Occupation; and (4) Whether the initial reporter also sent a copy of the report to us, if known. (e) Reporting information for all manufacturers (Form 3500A, Block G). You must submit the following: (1) Your reporting office's contact name and address and device manufacturing site; (2) Your telephone number; (3) Your report sources; (4) Date received by you (month, day, year); (5) Type of report being submitted (e.g., 5-day, initial, followup); and (6) Your report number. (f) Device manufacturer information (Form 3500A, Block H). You must submit the following: (1) Type of reportable event (death, serious injury, malfunction, etc.); (2) Type of followup report, if applicable (e.g., correction, response to FDA request, etc); (3) If the device was returned to you and evaluated by you, you must include a summary of the evaluation. If you did not perform an evaluation, you must explain why you did not perform an evaluation; (4) Device manufacture date (month, day, year); (5) Whether the device was labeled for single use; (6) Evaluation codes (including event codes, method of evaluation, result, and conclusion codes) (refer to FDA MEDWATCH Medical Device Reporting Code Instructions); (7) Whether remedial action was taken and the type of action; (8) Whether the use of the device was initial, reuse, or unknown; (9) Whether remedial action was reported as a removal or correction under section 519(f) of the act, and if it was, provide the correction/removal report number; and (10) Your additional narrative; and/or (11) Corrected data, including: (i) Any information missing on the user facility report or importer report, including any event codes that were not reported, or information corrected on these forms after your verification; (ii) For each event code provided by the user facility under §803.32(e)(10) or the importer under 803.42(e)(10), you must include a statement of whether the type of the event represented by the code is addressed in the device labeling; and (iii) If your report omits any required information, you must explain why this information was not provided and the steps taken to obtain this information. You must submit a 5-day report to us, on Form 3500A or an electronic equivalent approved under §803.14, no later than 5 work days after the day that you become aware that: (a) An MDR reportable event necessitates remedial action to prevent an unreasonable risk of substantial harm to the public health. You may become aware of the need for remedial action from any information, including any trend analysis; or (b) We have made a written request for the submission of a 5-day report. If you receive such a written request from us, you must submit, without further requests, a 5-day report for all subsequent events of the same nature that involve substantially similar devices for the time period specified in the written request. We may extend the time period stated in the original written request if we determine it is in the interest of the public health. (a) You must submit a baseline report for a device when you submit the first report under §803.50 involving that device model. Submit this report on FDA Form 3417 or an electronic equivalent approved under §803.14. (b) You must update each baseline report annually on the anniversary month of the initial submission, after the initial baseline report is submitted. Report changes to baseline information in the manner described in §803.56 (i.e., include only the new, changed, or corrected information in the appropriate portion(s) of the report form). In each baseline report, you must include the following information: (1) Name, complete address, and establishment registration number of your reporting site. If your reporting site is not registered under part 807, we will assign a temporary number for use in MDR reporting until you register your reporting site in accordance with part 807. We will inform you of the temporary MDR reporting number; (2) FDA registration number of each site where you manufacture the device; (3) Name, complete address, and telephone number of the individual who you have designated as your MDR contact, and the date of the report. For foreign manufacturers, we require a confirmation that the individual submitting the report is the agent of the manufacturer designated under §803.58(a); (4) Product identification, including device family, brand name, generic name, model number, catalog number, product code, and any other product identification number or designation; (5) Identification of any device that you previously reported in a baseline report that is substantially similar (e.g., same device with a different model number, or same device except for cosmetic differences in color or shape) to the device being reported. This includes additional identification of the previously reported device by model number, catalog number, or other product identification, and the date of the baseline report for the previously reported device; (6) Basis for marketing, including your 510(k) premarket notification number or PMA number, if applicable, and whether the device is currently the subject of an approved postmarket study under section 522 of the act; (7) Date that you initially marketed the device and, if applicable, the date on which you stopped marketing the device; (8) Shelf life of the device, if applicable, and expected life of the device; (9) The number of devices manufactured and distributed in the last 12 months and an estimate of the number of devices in current use; and (10) Brief description of any methods that you used to estimate the number of devices distributed and the number of devices in current use. If this information was provided in a previous baseline report, in lieu of resubmitting the information, it may be referenced by providing the date and product identification for the previous baseline report. Effective Date Note: At 61 FR 39869, July 31, 1996, in §803.55, paragraphs (b)(9) and (10) were stayed indefinitely. If you are a manufacturer, when you obtain information required under this part that you did not provide because it was not known or was not available when you submitted the initial report, you must submit the supplemental information to us within 1 month of the day that you receive this information. On a supplemental or followup report, you must: (a) Indicate on the envelope and in the report that the report being submitted is a supplemental or followup report. If you are using FDA form 3500A, indicate this in Block Item H–2; (b) Submit the appropriate identification numbers of the report that you are updating with the supplemental information (e.g., your original manufacturer report number and the user facility or importer report number of any report on which your report was based), if applicable; and (c) Include only the new, changed, or corrected information in the appropriate portion(s) of the respective form(s) for reports that cross reference previous reports. (a) Every foreign manufacturer whose devices are distributed in the United States shall designate a U.S. agent to be responsible for reporting in accordance with §807.40 of this chapter. The U.S. designated agent accepts responsibility for the duties that such designation entails. Upon the effective date of this regulation, foreign manufacturers shall inform FDA, by letter, of the name and address of the U.S. agent designated under this section and §807.40 of this chapter, and shall update this information as necessary. Such updated information shall be submitted to FDA, within 5 days of a change in the designated agent information. (b) U.S.-designated agents of foreign manufacturers are required to: (1) Report to FDA in accordance with §§803.50, 803.52, 803.53, 803.55, and 803.56; (2) Conduct, or obtain from the foreign manufacturer the necessary information regarding, the investigation and evaluation of the event to comport with the requirements of §803.50; (3) Forward MDR complaints to the foreign manufacturer and maintain documentation of this requirement; (4) Maintain complaint files in accordance with §803.18; and (5) Register, list, and submit premarket notifications in accordance with part 807 of this chapter. Effective Date Note: At 61 FR 38347, July 23, 1996, §803.58 was stayed indefinitely.
Title 21: Food and Drugs
PART 803—MEDICAL DEVICE REPORTING
Subpart E—Manufacturer Reporting Requirements
§ 803.50 If I am a manufacturer, what reporting requirements apply to me?
§ 803.52 If I am a manufacturer, what information must I submit in my individual adverse event reports?
§ 803.53 If I am a manufacturer, in which circumstances must I submit a 5-day report?
§ 803.55 If I am a manufacturer, in what circumstances must I submit a baseline report, and what are the requirements for such a report?
§ 803.56 If I am a manufacturer, in what circumstances must I submit a supplemental or followup report and what are the requirements for such reports?
§ 803.58 Foreign manufacturers.
